Sunday, May 31, 2026 | 10:22 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Concord Biotech Ltd / Announcements / BSE

Concord Biotech Ltd

Disclosure Under Of SEBI (LODR) Regulations 2015 Concord Biotech Secures Abbreviated New Drug Application (ANDA) Approval To Market Teriflunomide Tablets 7 Mg And 14 Mg In The US

06:00 PM, 8th Apr 2025

The company has been granted final approval from the USFDA for marketing its Teriflunomide tablets 7mg and 14mg

More Concord Biotech Ltd Announcements

    View more